Search Videos and More
News
ChatGPT and Medicine: The Good, the Bad, and the Bizarre
The artificial intelligence chatbot ChatGPT has wowed users with its seemingly human-like ability to generate and respond to language, and worried others by that very same ability.
Video
SABCS 2022: Sara Tolaney, MD, MPH
Updated data from the APT trial shows that after 10 years of follow-up, adjuvant paclitaxel and trastuzumab confirm excellent long-term outcomes for small, node-negative HER2-positive breast cancer.
Video
SABCS 2022: Paolo Tarantino, MD
ATEMPT study shows that 5 years after treatment, 97% of patient's w/stage 1 HER2+ breast cancer treated w/TDM1 were alive and free from invasive disease and 98.3% had no recurrence of their cancer.
Video
SABCS 2022: Ann Partridge, MD, MPH
Ann Partridge, MD, MPH, led the study presented at the 2022 San Antonio Breast Cancer Symposium which showed most women participating in the study went on to deliver healthy babies.
Video
SABCS 2022: Rachel Freedman, MD, MPH
Rachel Freedman, MD, MPH, shared results from the TBCRC 022 study where Neratinib in combination w/T-DM1 showed promising activity in patients w/heavily pre-treated HER2+ breast cancer metastatic to the central nervous system.
Symposium
2022 SABCS Highlights
Review highlights from the 45th annual San Antonio Breast Cancer Symposium. December 6 - 10, 2022.
News
Computer Platform Helps Match Patients With Cancer to Trials of Targeted Therapy
MatchMiner shortens time to identify appropriate precision medicine trials for individual patients
News
Monica Bertagnolli Named New Director of National Cancer Institute
Today, President Joe Biden announced that he is appointing Monica Bertagnolli, MD, surgical oncologist in the Dana-Farber Brigham Cancer Center and at Brigham and Women’s Hospital and member of the Gastrointestinal and Sarcoma Treatment Centers at Dana-Farber Cancer Institute, as director of the National Cancer Institute (NCI).
News
U.S. News & World Report Names Dana-Farber Brigham Cancer Center Among Nation's Best For 2022-2023
For the 22nd consecutive year, Dana-Farber Brigham Cancer Center has been recognized as a Best Hospital for cancer care by U.S. News & World Report. This year, Dana-Farber Brigham Cancer Center is ranked as the best hospital for cancer care in New England and #4 in the nation.
Video
Transatlantic Exchanges in Immuno-Oncology
Join our transatlantic panel of experts for an interactive, full-day virtual conference to be up to date with all the most exciting discoveries in immuno-oncology!
Video
Care and Innovation: Medical Oncology at Dana-Farber
Trace the remarkable growth and development of medical oncology at Dana-Farber — from its early roots to today's mission-driven commitment to excellence in research, care, collaboration, and training.
News
Cancer FactFinder Website Launched to Provide Fact-Based, Reliable Information About Causes of Cancer
A team led by the Zhu Family Center for Global Cancer Prevention at Harvard T.H. Chan School of Public Health and the Center for Cancer Equity and Engagement at the Dana-Farber/Harvard Cancer Center has launched a new website that provides accurate and reliable information about what does and does not cause cancer.